These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 6208038

  • 1. Synergistic protection by specific antibodies and interferon against infection by Trypanosoma cruzi in vitro.
    Plata F, Wietzerbin J, Pons FG, Falcoff E, Eisen H.
    Eur J Immunol; 1984 Oct; 14(10):930-5. PubMed ID: 6208038
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL, Antúnez MI, Abrami AA.
    Medicina (B Aires); 1999 Oct; 59 Suppl 2():84-90. PubMed ID: 10668248
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Trypanosoma cruzi infection does not impair major histocompatibility complex class I presentation of antigen to cytotoxic T lymphocytes.
    Buckner FS, Wipke BT, Van Voorhis WC.
    Eur J Immunol; 1997 Oct; 27(10):2541-8. PubMed ID: 9368608
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi.
    Hoft DF, Lynch RG, Kirchhoff LV.
    J Immunol; 1993 Dec 15; 151(12):7038-47. PubMed ID: 8258708
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice.
    Torrico F, Heremans H, Rivera MT, Van Marck E, Billiau A, Carlier Y.
    J Immunol; 1991 May 15; 146(10):3626-32. PubMed ID: 1902858
    [Abstract] [Full Text] [Related]

  • 13. Macrophage activity, IL-6 levels, antibody response and heart histology in rats undergoing an attenuated Trypanosoma cruzi acute infection upon treatment with recombinant interferon gamma.
    Revelli S, Didoli G, Roggero E, Moreno H, Bernabo J, Wietzerbin J, Bottasso O.
    Cytokines Cell Mol Ther; 1998 Sep 15; 4(3):153-9. PubMed ID: 9825840
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. IL-10 mediates susceptibility to Trypanosoma cruzi infection.
    Reed SG, Brownell CE, Russo DM, Silva JS, Grabstein KH, Morrissey PJ.
    J Immunol; 1994 Oct 01; 153(7):3135-40. PubMed ID: 8089491
    [Abstract] [Full Text] [Related]

  • 18. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.
    Duan X, Yonemitsu Y, Chou B, Yoshida K, Tanaka S, Hasegawa M, Tetsutani K, Ishida H, Himeno K, Hisaeda H.
    Vaccine; 2009 Oct 19; 27(44):6154-9. PubMed ID: 19712768
    [Abstract] [Full Text] [Related]

  • 19. Trypanosoma cruzi: exposure of murine cells to live parasites in vitro leads to enhanced surface class I MHC expression which is type I interferon-dependent.
    Stryker GA, Nickell SP.
    Exp Parasitol; 1995 Dec 19; 81(4):564-73. PubMed ID: 8542998
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.